Peripheral Nervous System Diseases Withdrawn Phase 2 Trials for Selumetinib (DB11689)

Also known as: Peripheral Nervous System Disorders / Peripheral Nervous System Disease / Neuropathy peripheral / Peripheral nerve disorder NOS / Peripheral neuropathy NOS / Peripheral neuropathy / Peripheral neuropathies / Disorder of peripheral nervous system NOS / Peripheral nerve disease (disorder) / Disorder of the peripheral nervous system (disorder)

IndicationStatusPhase
DBCOND0029829 (Peripheral Nervous System Diseases)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03109301
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)Treatment